Polycythaemia vera, ruxolitinib, and hydroxyurea: where do we go now?

被引:2
作者
Spivak, Jerry L. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Hematol Div, Baltimore, MD 21205 USA
关键词
THERAPY; CELL;
D O I
10.1016/S2352-3026(19)30262-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E184 / E185
页数:2
相关论文
共 10 条
[1]   Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project [J].
Barosi, Giovanni ;
Mesa, Ruben ;
Finazzi, Guido ;
Harrison, Claire ;
Kiladjian, Jean-Jacques ;
Lengfelder, Eva ;
McMullin, Mary F. ;
Passamonti, Francesco ;
Vannucchi, Alessandro M. ;
Besses, Carlos ;
Gisslinger, Heinz ;
Samuelsson, Jan ;
Verstovsek, Srdan ;
Hoffman, Ronald ;
Pardanani, Animesh ;
Cervantes, Francisco ;
Tefferi, Ayalew ;
Barbui, Tiziano .
BLOOD, 2013, 121 (23) :4778-4781
[2]   INCREASED INCIDENCE OF ACUTE-LEUKEMIA IN POLYCYTHEMIA-VERA ASSOCIATED WITH CHLORAMBUCIL THERAPY [J].
BERK, PD ;
GOLDBERG, JD ;
SILVERSTEIN, MN ;
WEINFELD, A ;
DONOVAN, PB ;
ELLIS, JT ;
LANDAW, SA ;
LASZLO, J ;
NAJEAN, Y ;
PISCIOTTA, AV ;
WASSERMAN, LR .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (08) :441-447
[3]   Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia [J].
Harrison, CN ;
Campbell, PJ ;
Buck, G ;
Wheatley, K ;
East, CL ;
Bareford, D ;
Wilkins, BS ;
van der Walt, JD ;
Reilly, JT ;
Grigg, AP ;
Revell, P ;
Woodcock, BE ;
Green, AR ;
Pearson, TC ;
Conneally, E ;
Crawley, C ;
Cross, NCP ;
Hall, G ;
Hunt, B ;
Lucas, G ;
Ludlam, C ;
McMullin, MF ;
Oscier, D ;
Radia, D ;
Reilly, JT ;
Robinson, G ;
Culligan, DJ ;
Tighe, J ;
Watson, HG ;
Warren, AJ ;
Awaad, MO ;
Obeid, D ;
Cuthbert, RJG ;
Kyle, A ;
Chan-Lam, D ;
Paul, B ;
Cuthbert, RJG ;
McMullin, MF ;
Morris, TCM ;
Johnson, RJ ;
Fegan, C ;
Milligan, DW ;
Galloway, MJ ;
Williamson, PJ ;
Newton, LJ ;
Williams, AT ;
Abboudi, Z ;
Ryan, K ;
Lush, R ;
Blundell, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (01) :33-45
[4]   Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study [J].
Kiladjian, Jean-Jacques ;
Zachee, Pierre ;
Hino, Masayuki ;
Pane, Fabrizio ;
Masszi, Tamas ;
Harrison, Claire N. ;
Mesa, Ruben ;
Miller, Carole B. ;
Passamonti, Francesco ;
Durrant, Simon ;
Griesshammer, Martin ;
Kirito, Keita ;
Besses, Carlos ;
Beatriz Moiraghi, Elena ;
Rumi, Elisa ;
Rosti, Vittorio ;
Blau, Igor Wolfgang ;
Francillard, Nathalie ;
Dong, Tuochuan ;
Wroclawska, Monika ;
Vannucchi, Alessandro M. ;
Verstovsek, Srdan .
LANCET HAEMATOLOGY, 2020, 7 (03) :E226-E237
[5]   Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera [J].
Kralovics, R ;
Guan, YL ;
Prchal, JT .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (03) :229-236
[6]   THE NATURE AND TREATMENT OF POLYCYTHEMIA - STUDIES ON 263 PATIENTS [J].
LAWRENCE, JH ;
BERLIN, NI ;
HUFF, RL .
MEDICINE, 1953, 32 (03) :323-388
[7]   Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies [J].
Mesa, Ruben A. ;
Kiladjian, Jean-Jacques ;
Verstovsek, Srdan ;
Al-Ali, Haifa Kathrin ;
Gotlib, Jason ;
Gisslinger, Heinz ;
Levy, Richard ;
Siulnik, Andres ;
Gupta, Vikas ;
Khan, Mahmudul ;
DiPersio, John F. ;
McQuitty, Mari ;
Catalano, John V. ;
Hunter, Deborah S. ;
Knoops, Laurent ;
Deininger, Michael ;
Cervantes, Francisco ;
Miller, Carole ;
Vannucchi, Alessandro M. ;
Silver, Richard T. ;
Barbui, Tiziano ;
Talpaz, Moshe ;
Barosi, Giovanni ;
Winton, Elliott F. ;
Mendeson, Estella ;
Harvey, Jimmie H., Jr. ;
Arcasoy, Murat O. ;
Hexner, Elizabeth ;
Lyons, Roger M. ;
Paquette, Ronald ;
Raza, Azra ;
Sun, William ;
Sandor, Victor ;
Kantarjian, Hagop M. ;
Harrison, Claire .
HAEMATOLOGICA, 2014, 99 (02) :292-298
[8]   Phenotypic variability within the JAK2 V617F-positive MPD: Roles of progenitor cell and neutrophil allele burdens [J].
Moliterno, Alison R. ;
Williams, Donna M. ;
Rogers, Ophelia ;
Isaacs, Mary Ann ;
Spivak, Jerry L. .
EXPERIMENTAL HEMATOLOGY, 2008, 36 (11) :1480-1486
[9]  
Stein Brady L, 2011, Thrombosis, V2011, P874146, DOI 10.1155/2011/874146
[10]   Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera [J].
Vannucchi, Alessandro M. ;
Kiladjian, Jean Jacques ;
Griesshammer, Martin ;
Masszi, Tamas ;
Durrant, Simon ;
Passamonti, Francesco ;
Harrison, Claire N. ;
Pane, Fabrizio ;
Zachee, Pierre ;
Mesa, Ruben ;
He, Shui ;
Jones, Mark M. ;
Garrett, William ;
Li, Jingjin ;
Pirron, Ulrich ;
Habr, Dany ;
Verstovsek, Srdan .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (05) :426-435